INSIGHTS ON PHARMACEUTICAL PACKAGING

• The Constraints And Innovations In The Packaging Of Biologic Drugs

  Biologic therapies require specialized packaging to prevent drug degradation. Discover how advanced primary containment systems overcome stability and delivery challenges for patient care.

• Determining The Limit Of Detection In CCIT

  Accurately determining the smallest detectable defect in pharmaceutical packaging is essential for sterility. Learn how test sensitivity, positive controls, and regulatory standards shape CCI strategies.

• De-Risking The Transition From Vial To Drug-Device Combination Product

  When transitioning from a vial to a combination product system, the best approach is to have a holistic de-risk strategy with an intentional focus on the patient, the plan, and the product.

• West Vantage™ Goes Beyond Contract Manufacturing

  Successfully advancing a drug-delivery device to market demands more than technical expertise; it requires coordinated execution, regulatory insight, and the ability to scale without disruption.

• The Leader In Pharmaceutical, Process, And Packaging Equipment

  2/6/2025

  Discover the leading source for used industrial equipment in pharma and processing. With a huge inventory and decades of expertise, find cost-effective machinery solutions that meet your needs.

• Blister Solutions

  3/4/2025

  With over 6,000 tooling parts and an in-house machining center to ensure precision, explore this versatile blister service that provides both Thermoformed and Cold-Formed solutions.

• Vial Containment Systems Based On Elastomer 4031/45 Gray

  10/1/2024

  Examine the results of two, two-year studies that indicate good container closure integrity performance that can be achieved with stoppers of a given elastomer, independent of configuration.

• New Standards For Elastomeric Components In Sterile Packaging

  1/20/2026

  USP’s new elastomeric packaging standards shift testing to full system‑level evaluation, strengthen integrity and usability expectations, and place compliance responsibility on drug developers.

• Considerations For Handling A Drug Product With Ultra-Low Temperature Requirements

  9/3/2026

  Maintaining product integrity at ultra-low temperatures is complex. Learn key packaging, validation, and supply chain considerations for advanced therapies.